Criteria for initiating chemotherapy in patients after evacuation of hydatidiform mole

Tumor Biology

Volumn 24, Issue 3, 2003, Pages 140-146

  Matsui, Hideo ^a   Iitsuka, Yoshinori ^a   Yamazawa, Koji ^a   Tanaka, Naotake ^a   Mitsuhashi, Akira ^a   Seki, Katsuyoshi ^a   Sekiya, Souei ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diagnosis; Gestational trophoblastic tumor; Human chorionic gonadotropin

Indexed keywords

CHORIONIC GONADOTROPIN; DACTINOMYCIN; ETOPOSIDE; METHOTREXATE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER REGRESSION; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GYNECOLOGY; HUMAN; HYDATIDIFORM MOLE; JAPAN; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; OBSTETRICS; PRIORITY JOURNAL; TROPHOBLASTIC TUMOR;

EID: 0345257912     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073843     Document Type: Article

References (19)

1. Kohorn EI: Single-agent chemotherapy for nonmetastatic gestational trophoblastic neoplasia. Perspectives for the 21st century after three decades of use. J Reprod Med 1991;36: 49-55.
2. Lurain JR, Elfstrand EP: Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors. Am J Obstet Gynecol 1995;172:574-579.
3. Bagshawe KD, Dent J, Webb J: Hydatidiform mole in England and Wales 1973-1983. Lancet 1986;ii:673-677.
4. Kohorn EI: Evaluation of the criteria used to make the diagnosis of nonmetastatic gestational trophoblastic neoplasia. Gynecol Oncol 1993;48:139-147.
5. Eguchi O, Matsui H, Inaba N, Takamizawa H: A study on a new follow-up system of postmolar pregnancy (in Japanese). Chiba Med J 1993; 69:97-102.
6. Berger P, Sturgeon C, Bidart JM, Paus E, Gerth R, Niang M, Bristow A, Birken S, Stenman UH: The ISOBM TD-7 workshop on hCG and related molecules. Towards user-oriented standardization of pregnancy and tumor diagnosis: Assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives. Tumor Biol 2002;23:1-38.
7. Schlaerth JB, Morrow CP, Kletzky OA, Nalick RH, D'Ablaing GA: Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy. Obstet Gynecol 1981;58:478-482.
8. Bagshawe KD, Wilson H, Dublon P, Smith A, Balwin M, Kardana A: Follow-up after hydatidiform mole: Studies using radioimmunoas-say for urinary human chorionic gonadotropin (HCG). J Obstet Gynaecol Br Commonw 1973; 80:461-468.
9. Franke HR, Risse EKJ, Kenemans P, Houx PCW, Stolk JG, Vooijs GP: Plasma human chorionic gonadotropin disappearance in hydatidiform mole: A central registry report from the Netherlands. Obstet Gynecol 1983;62:467-473.
10. Yedema KA, Verheijen RH, Kenemans P, Schijf CP, Borm GF, Segers MF, Thomas CM: Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve. Am J Obstet Gynecol 1993;168:787-792.
11. Shigematsu T, Kamura T, Saito T, Kaku T, Nakano H, Kinugawa N: Identification of persistent trophoblastic diseases on a human chorionic gonadotropin regression curve by means of a stepwise piecewise linear regression analysis after evacuation of uneventful moles. Gynecol Oncol 1998;71:376-380.
12. Matsui H, Iitsuka Y, Yamazawa K, Tanaka N, Seki K, Sekiya S: Changes in the incidence of molar pregnancies. A population-based study in Chiba Prefecture and Japan between 1974 and 2000. Hum Reprod 2003;18:172-175.
13. Matsui H, Iitsuka Y, Seki K, Sekiya S: Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease: Remission rates and drug toxicities. Gynecol Obstet Invest 1998;46: 5-8.
14. Kohorn EI: Hydatidiform mole and gestational trophoblastic disease in Southern Connecticut. Obstet Gynecol 1982;59:78-84.
15. Berkowitz RS, Goldstein DP, Bernstein MR: Ten year's experience with methotrexate and folic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol 1985;23: 111-118.
16. Lurain JR, Brewer JI, Torok EE, Halpern B: Gestational trophoblastic disease: Treatment results at the Brewer Trophoblastic Disease Center. Obstet Gynecol 1982;60:354-360.
17. Flam F, Lundstrom V: Twenty years' experience of treating gestational neoplasia in Sweden. Acta Obstet Gynecol Scand 1989;68:65-69.
18. Wong LC, Choo YC, Ma HK: Primary oral etoposide therapy in gestational trophoblastic disease. An update. Cancer 1986;58:14-17.
19. Mutch DG, Soper JT, Baker ME, Bandy LC, Cox EB, Clarke-Pearson DL, Hammond CB: Role of computed axial tomography of the chest in staging patients with nonmetastatic gestational trophoblastic disease. Obstet Gynecol 1986;68:348-352.